S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice
Journal of Lipid Research · 2025-05 · 66 (5) · 100794
DOI: 10.1016/j.jlr.2025.100794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025-05. Verfasst von María R Luque-Urbano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Atlas Molecular Pharma, Derio, Spain; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spai…. Hauptthemen laut MEDLINE: S-Adenosylmethionine, Liver, Lipoproteins, VLDL, Lipid Metabolism. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Hepatic deletion of methionine adenosyltransferase-1a (Mat1a) in mice reduces S-adenosylmethionine (SAMe), a key methyl donor essential for many biological processes, which promotes the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Hyperglycemia and reduced MAT1A expression, along with low SAMe levels, are common in MASLD patients. This study explores how Mat1a-knockout (KO) hepatocytes respond to prolonged high glucose conditions, focusing on glucose metabolism and lipid accumulation. Hepatocytes from methionine adenosyltransferase-1a-knockout (Mat1a-KO) mice were incubated in high glucose conditions overnight, allowing for analysis of key metabolic intermediates and gene expression related to glycolysis, gluconeogenesis, glyceroneogenesis, phospholipid synthesis, and very low density lipoprotein (VLDL) secretion. SAMe deficiency in Mat1a-KO hepatocytes led to reduced protein methyltransferase-1 activity, resulting in increased expression of glycolytic enzymes (glucokinase, phosphofructokinase, and pyruvate kinase) and decreased expression of gluconeogenic enzymes (phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase). These alterations led to a reduction in dihydroxyacetone phosphate (DHAP), which subsequently inhibited mammalian target of rapamycin complex 1 (mTORC1) activity. This inhibition resulted in decreased phosphatidylcholine synthesis via the CDP-choline pathway and impaired VLDL secretion, ultimately causing lipid accumulation. Thus, under high glucose conditions, SAMe deficiency in hepatocytes depletes DHAP, inhibits mTORC1 activity, and promotes lipid buildup.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Atlas Molecular Pharma, Derio, Spain; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.
- Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
- Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.
- Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Atlas Molecular Pharma, Derio, Spain; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
- Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: director@cicbiogune.es.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
- Ministerio de Ciencia e Innovación
- Instituto de Salud Carlos III
- Ministerio de Economía y Competitividad
- Biomedical Research Network Center of Hepatic and Digestive Diseases
- European Regional Development Fund
- Basque Government
Zitieren
APA
Luque-Urbano, M. R., Fernández-Ramos, D., Lopitz-Otsoa, F., Gutiérrez de Juan, V., Bizkarguenaga, M., Castro-Espadas, L., Hermoso-Martínez, U., Barbier-Torres, L., Lu, S. C., Millet, O., & Mato, J. M. (2025). S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice. Journal of Lipid Research, 66(5), 100794. https://doi.org/10.1016/j.jlr.2025.100794
Vancouver
Luque-Urbano MR, Fernández-Ramos D, Lopitz-Otsoa F, Gutiérrez de Juan V, Bizkarguenaga M, Castro-Espadas L, et al. S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice. Journal of Lipid Research. 2025;66(5):100794. doi:10.1016/j.jlr.2025.100794
BibTeX
@article{LuqueUrbano2025,
author = {Luque-Urbano, María R and Fernández-Ramos, David and Lopitz-Otsoa, Fernando and Gutiérrez de Juan, Virginia and Bizkarguenaga, Maider and Castro-Espadas, Lia and Hermoso-Martínez, Uxue and Barbier-Torres, Lucía and Lu, Shelly C and Millet, Oscar and Mato, José M},
title = {S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice},
journal = {Journal of Lipid Research},
year = {2025},
volume = {66},
number = {5},
pages = {100794},
doi = {10.1016/j.jlr.2025.100794}
}
EUVIMED